Clinical trial

Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using DOSI

NCT02725658

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2015-12-01

PhaseNA

Study timeline

Study start (unknown)2015-12-01Date precision: month

Registry last updated2022-11-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Tumorunresolved

Interventions

DOSIDEVICE

Sponsors & collaborators

Beckman Laser Institute and Medical Centerlead sponsor

Beckman Laser Institute University of California Irvinecollaborator

University of California, San Franciscocollaborator

Mapped research locations

IrvineCalifornia, United States2 San FranciscoCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02725658 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.